刘瑞青,曹会存,曹广劭,李辉,刘健,刘玉岩,李陆鹏,刘建文.子宫动脉栓塞联合刮宫术治疗瘢痕妊娠疗效及其远期影响[J].中国介入影像与治疗学,2018,15(10):597-600
子宫动脉栓塞联合刮宫术治疗瘢痕妊娠疗效及其远期影响
Effect of uterine artery chemoembolization combined with dilatation and curettage for scar pregnancy and its long-term impact on patients
投稿时间:2018-01-05  修订日期:2018-05-24
DOI:10.13929/j.1672-8475.201801009
中文关键词:  妊娠,异位  子宫动脉  栓塞,治疗性  刮宫术
英文关键词:Pregnancy,ectopic  Uterine artery  Embolization,therapeutic  Dilatation and curettage
基金项目:
作者单位E-mail
刘瑞青 河南省人民医院综合介入科, 河南 郑州 450003  
曹会存 河南省人民医院综合介入科, 河南 郑州 450003  
曹广劭 河南省人民医院综合介入科, 河南 郑州 450003  
李辉 河南省人民医院综合介入科, 河南 郑州 450003  
刘健 河南省人民医院综合介入科, 河南 郑州 450003  
刘玉岩 河南省人民医院综合介入科, 河南 郑州 450003  
李陆鹏 河南省人民医院综合介入科, 河南 郑州 450003  
刘建文 河南省人民医院综合介入科, 河南 郑州 450003 jrkliiu@126.com 
摘要点击次数: 949
全文下载次数: 572
中文摘要:
      目的 探讨子宫动脉化疗栓塞(UACE)联合刮宫术治疗瘢痕妊娠(CSP)的疗效及其远期影响。方法 连续收集接受UACE联合刮宫术治疗的101例CSP患者,评价UACE预防刮宫时大出血等严重后果的作用,术后随访月经复潮时间、月经周期是否规律、行经时间及月经量情况,采用SPSS 17.0软件分析各因素对患者术后月经量的影响。结果 101例中,仅2例发生刮宫时大出血;UACE临床成功率98.02%(99/101)。术后中位随访时间37.5个月(16.5~65.5个月),中位月经复潮时间1.5个月(0.5~3.0个月),月经周期规律,中位行经时间3天(1~5天)。60例术后月经量减少(包括1例闭经),41例术后月经量正常。术后月经量减少与月经量正常患者间年龄、术前β-人绒毛膜促性腺激素(β-HCG)水平、流产次数、剖宫产次数、刮宫术距UACE的间隔时间、刮宫术中清出组织重量及术中出血量差异均无统计学意义(P均>0.05),UACE栓塞材料差异亦无统计学意义(χ2=1.10,P=0.58)。结论 UACE联合刮宫术治疗CSP安全、有效,但存在术后月经量减少及闭经风险。
英文摘要:
      Objective To investigate the effect of uterine artery chemoembolization (UACE) combined with dilatation and curettage for scar pregnancy (CSP) and its long-term impact on the patients.Methods Totally 101 CSP patients were enrolled and treated with UACE combined with dilatation and curettage. The effect of UACE on prevention of severe bleeding during curettage was evaluated. Postoperative follow-up was performed to collect clinical information, including the time of menstruation recovery, menstruation regular or not, menstrual period and menstrual volume. The impact of clinical factors on the changes of postoperative menstrual volume was analyzed with SPSS 17.0 software.Results Severe bleeding during curettage occurred in 2 patients. The clinical success rate of UACE was 98.02% (99/101). The median follow-up time was 37.5 months (16.5-65.5 months). The menstruation was regular, the median time of menstruation recovery and menstrual period was 1.5 months (0.5-3.0 months) and 3 days (1-5 days), respectively. There were 60 patients with decreasing menstrual volume (including 1 case of amenorrhea) and 41 patients with normal menstrual volume after treatment. The differences of patients' age, preoperative level of β-human chorionic gonadotropin (β-HCG), abortion times, cesarean delivery times, interval of cesarean and UACE, weigh of curettage tissue and blood loss during curettage were not statistically significant between patients with decreasing and normal menstrual volume after treatment (all P>0.05). Meanwhile, there was no statistical difference of embolization material of UACE between patients with decreasing and normal menstrual volume after treatment (χ2=1.10, P=0.58).Conclusion UACE combined with dilatation and curettage for CSP is safe and effective. However, some patients may have decreased menstrual flow even amenorrhea after treatment.
查看全文  查看/发表评论  下载PDF阅读器
关闭